Heart Disease
With $41.9 Million from Oversubscribed Financing Round, XyloCor Sets Sights on Gene Therapy for Heart Disease
2021-03-23
Verve Raises $94M in Series B, Aims to Disrupt Cardiology Market with ‘Once-and-Done’ Gene Editing Therapies
2021-01-21
Encouraging Performance of Cardiovascular Drug Vindicates Novartis’ $9.7 Billion Buyout Deal
2020-09-06
LATEST
American Heart Association Reports 400 Milligrams of Daily Caffeine Is Safe for Most Adults
2026-07-20
Translational Frontiers in Regenerative Medicine: Navigating Clinical Bottlenecks and Commercial Scale for Advanced Cell Therapies
2026-07-20
National Bank of Georgia Partners with Nasdaq Calypso to Modernize Treasury Infrastructure for Five Major Banks
2026-07-20
WCC BIOMEDICAL Overcomes Microneedle Array Patches Manufacturing Challenges, Advancing Next-Generation Drug Delivery
2026-07-18
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




